In some landmark preclinical work, we took rare mutations that caused familial forms of AD, developed mouse models that overproduced amyloid, and then developed antibodies and vaccines against this target. ###>Enfin, nous avons mis au point des anticorps et des vaccins ciblant cette protéine.